{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:38:53Z","timestamp":1775137133051,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.carrev.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T21:19:06Z","timestamp":1646860746000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Durability of Surgical and Transcatheter Aortic Bioprostheses: A Review of the Literature"],"prefix":"10.1016","volume":"42","author":[{"given":"Matteo","family":"Casenghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Popolo Rubbio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Menicanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2022.03.006_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtcvs.2008.08.015","article-title":"Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database","volume":"137","author":"Brown","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0010","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2022.03.006_bb0015","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2022.03.006_bb0020","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT registry of transcatheter aortic valve replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0025","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/eurheartj\/ehx303","volume":"38","author":"Capodanno","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2022.03.006_bb0030","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.athoracsur.2007.12.082","article-title":"Guidelines for reporting mortality and morbidity after cardiac valve interventions","volume":"85","author":"Akins","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0035","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/eurheartj\/ehz925","article-title":"Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis","volume":"41","author":"Testa","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2022.03.006_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2020.10.053","article-title":"Transcatheter replacement of transcatheter versus surgically implanted aortic valve bioprostheses","volume":"77","author":"Landes","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0045","first-page":"483","article-title":"Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis","volume":"16","author":"Le Tourneau","year":"2007","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.carrev.2022.03.006_bb0050","doi-asserted-by":"crossref","first-page":"I512","DOI":"10.1161\/CIRCULATIONAHA.105.000422","article-title":"Metabolic syndrome is associated with faster degeneration of bioprosthetic valves","volume":"114","author":"Briand","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacc.2017.07.715","article-title":"Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration","volume":"70","author":"Rodriguez-Gabella","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.108.778886","article-title":"Prosthetic heart valves: selection of the optimal prosthesis and long-term management","volume":"119","author":"Pibarot","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0065","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/CIRCULATIONAHA.109.901272","article-title":"Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves","volume":"121","author":"Flameng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrcardio.2016.43","article-title":"Durability of prostheses for transcatheter aortic valve implantation","volume":"13","author":"Arsalan","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.90.1.323","article-title":"Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves","volume":"90","author":"Chen","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCULATIONAHA.105.549311","article-title":"Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection","volume":"114","author":"Manji","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0085","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/eurheartj\/ehu388","article-title":"Transcatheter heart valve failure: a systematic review","volume":"36","author":"Mylotte","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2022.03.006_bb0090","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.athoracsur.2013.11.009","article-title":"The effects of transcatheter valve crimping on pericardial leaflets","volume":"97","author":"Alavi","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0095","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0340","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0003-4975(96)00531-0","article-title":"Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity","volume":"62","author":"Edmunds","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0360","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1067\/mtc.2001.112208","article-title":"Late results of heart valve replacement with the Hancock II bioprosthesis","volume":"121","author":"David","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.carrev.2022.03.006_bb0165","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jtcvs.2013.07.005","article-title":"Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position","volume":"147","author":"Anselmi","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0390","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.114.010400","article-title":"Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients","volume":"130","author":"S\u00e9nage","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0400","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ehjci\/jew025","volume":"17","author":"Lancellotti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2022.03.006_bb0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","article-title":"Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves","volume":"137","author":"Dvir","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0405","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacc.2018.10.083","article-title":"Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk","volume":"73","author":"S\u00f8ndergaard","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0105","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0110","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.athoracsur.2016.05.080","article-title":"Pericardial stentless valve for aortic valve replacement: long-term results","volume":"102","author":"Repossini","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jocs.12726","article-title":"Long-term outcomes and durability of the mitroflow aortic bioprosthesis","volume":"31","author":"Mosquera","year":"2016","journal-title":"J Card Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0120","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejcts.2009.05.020","article-title":"Mitroflow aortic pericardial bioprosthesis\u2013clinical performance","volume":"36","author":"Jamieson","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0125","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.114.010400","article-title":"Early structural valve deterioration of mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients","volume":"130","author":"S\u00e9nage","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0003-4975(01)02992-7","article-title":"Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis","volume":"72","author":"Banbury","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/mtc.2002.121672","article-title":"Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis","volume":"124","author":"Dellgren","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.athoracsur.2019.12.071","article-title":"Trifecta versus Perimount magna ease aortic valve prostheses","volume":"110","author":"Biancari","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0145","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jtcvs.2019.11.028","article-title":"Durability and clinical experience using a bovine pericardial prosthetic aortic valve","volume":"161","author":"Lehmann","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0150","doi-asserted-by":"crossref","first-page":"602-9","DOI":"10.1016\/j.jtcvs.2006.05.031","article-title":"Fifteen-year results with the Hancock II valve: a multicenter experience","volume":"132","author":"Rizzoli","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0155","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.athoracsur.2012.05.003","article-title":"Long-term results of the Carpentier-Edwards supraannular aortic valve prosthesis","volume":"94","author":"Ruggieri","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jtcvs.2010.08.090","article-title":"Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance","volume":"142","author":"Jamieson","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0170","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.athoracsur.2008.05.058","article-title":"Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position","volume":"86","author":"Eichinger","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0175","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/jocs.14837","article-title":"Long-term clinical outcomes of the Toronto stentless porcine valve: 15-year results from dual centers","volume":"35","author":"Une","year":"2020","journal-title":"J Card Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0180","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jtcvs.2004.01.023","article-title":"Eight-year results after aortic valve replacement with the freestyle stentless bioprosthesis","volume":"127","author":"Bach","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0185","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.athoracsur.2005.03.027","article-title":"Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis","volume":"80","author":"Bach","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0190","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4244\/EIJ-D-18-00779","article-title":"Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years","volume":"14","author":"Panico","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.03.006_bb0195","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","article-title":"5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients","volume":"72","author":"Gleason","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0200","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","article-title":"5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Kapadia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2022.03.006_bb0205","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2022.03.006_bb0210","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.118.036866","article-title":"Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients","volume":"138","author":"Didier","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0215","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jcin.2019.12.026","article-title":"5-Year outcomes after TAVI with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial","volume":"13","author":"Abdel-Wahab","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0220","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jacc.2018.10.078","article-title":"Long-term durability of transcatheter aortic valve prostheses","volume":"73","author":"Blackman","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4244\/EIJ-D-17-00603","article-title":"Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVI with first-generation devices","volume":"14","author":"Deutsch","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.03.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008440","article-title":"Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement","volume":"7","author":"Barbanti","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2022.03.006_bb0235","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4244\/EIJ-D-18-00015","article-title":"Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition","volume":"14","author":"Eltchaninoff","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.03.006_bb0240","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","article-title":"Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement","volume":"42","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2022.03.006_bb0245","first-page":"E431","article-title":"Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement","volume":"97","author":"Sathananthan","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0250","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.jacc.2019.03.483","article-title":"3-Year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses: the PARTNER 2 registry","volume":"73","author":"Webb","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0255","article-title":"One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system","author":"Casenghi","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0260","first-page":"1404","article-title":"Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: a systematic review and meta-analysis","volume":"92","author":"Tam","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0265","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0270","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2019.03.035","article-title":"The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVI coronary obstruction","volume":"12","author":"Khan","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0275","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009017","article-title":"Outcome of coronary ostial stenting to prevent coronary obstruction during transcatheter aortic valve replacement","volume":"13","author":"Mangieri","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0295","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.athoracsur.2017.04.007","article-title":"Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation","volume":"104","author":"Allen","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0280","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jacc.2018.09.001","article-title":"Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS\/ACC TVT registry","volume":"72","author":"Herrmann","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2014.7246","article-title":"Transcatheter aortic valve implantation in failed bioprosthetic surgical valves","volume":"312","author":"Dvir","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2022.03.006_bb0290","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jacc.2018.04.074","article-title":"Transcatheter aortic valve replacement of failed surgically implanted bioprostheses: the STS\/ACC registry","volume":"72","author":"Tuzcu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0300","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.jacc.2020.02.051","article-title":"Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction","volume":"75","author":"Landes","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0305","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.jcin.2020.09.022","article-title":"Risk of coronary obstruction due to sinus sequestration in redo transcatheter aortic valve replacement","volume":"13","author":"Ochiai","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0310","first-page":"678","article-title":"Bailout from sinus jailing: in-series TAVI-in-TAVI to avoid coronary flow obstruction","volume":"3","author":"Casenghi","year":"2021","journal-title":"J Am Coll Cardiol Case Rep"},{"key":"10.1016\/j.carrev.2022.03.006_bb0345","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jtcvs.2008.05.022","article-title":"Aortic valve replacement with the mitroflow pericardial bioprosthesis: durability results up to 21 years","volume":"136","author":"Yankah","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0350","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.athoracsur.2014.09.030","article-title":"Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position","volume":"99","author":"Bourguignon","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0355","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jtcvs.2008.05.068","article-title":"A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis","volume":"137","author":"Myk\u00e9n","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0365","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5223(02)73618-0","article-title":"Long-term durability of the Hancock II porcine bioprosthesis","volume":"126","author":"Rizzoli","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0370","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jtcvs.2012.08.060","article-title":"Durability of pericardial versus porcine bioprosthetic heart valves","volume":"144","author":"Grunkemeier","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0375","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jacc.2004.01.053","article-title":"Durability of pericardial versus porcine aortic valves","volume":"44","author":"Gao","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.03.006_bb0380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtcvs.2007.04.068","article-title":"Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability","volume":"135","author":"David","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0385","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jtcvs.2014.02.063","article-title":"Long-term results of freestyle stentless bioprosthesis in the aortic position: a single-center prospective cohort of 500 patients","volume":"148","author":"Amabile","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0315","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.03.006_bb0320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"60","author":"Vahanian","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.carrev.2022.03.006_bb0325","first-page":"E847","article-title":"A patient-specific algorithm to achieve commissural alignment with accurate neo: the sextant technique","volume":"98","author":"De Marco","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0330","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.jcin.2021.09.019","article-title":"Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis","volume":"14","author":"Bogyi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.03.006_bb0335","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jacc.2012.08.1039","article-title":"Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature","volume":"61","author":"G\u00e9n\u00e9reux","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:25:04Z","timestamp":1761560704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838922001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":80,"alternative-id":["S1553838922001191"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2022.03.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durability of Surgical and Transcatheter Aortic Bioprostheses: A Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}